Sign in

CIK 0002070849 · Non-accelerated filer<br>Emerging growth company

BillionToOne, Inc.

Sign in to watch
Ticker
BLLN
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
811082020
Phone
650-460-2551
Business address
1035 O'BRIEN DRIVE, MENLO PARK, CA
  1. 4 Planned sale SVP of Laboratory Operations sold 1,416 shares at $120.00 ($169,920)
  2. 4 Planned sale Chief Product Officer sold 8,000 shares at $110.00 ($880,000)
  3. 4 Planned sale See Remarks sold 2,832 shares at $101.47 ($287,363)
  4. 4 Planned sale Chief Technology Officer sold 20,000 shares at an average $102.27 ($2,045,326)
  5. 4 Grant or award Director acquired 3,017 shares (grant or award)
  6. 4 Grant or award Director acquired 3,017 shares (grant or award)
  7. 4 Grant or award Director acquired 3,017 shares (grant or award)
  8. 4 Grant or award Director acquired 3,017 shares (grant or award)
  9. 4 Grant or award Director acquired 3,017 shares (grant or award)
  10. 4 Other disposition Director disposed of 450,779 shares (other)
  11. 4 Other disposition 10% owner disposed of 450,779 shares (other)
  12. 4 Planned sale Chief Product Officer sold 8,000 shares at an average $98.23 ($785,800)
  13. 4 Planned sale See Remarks sold 14,000 shares at an average $100.18 ($1,402,540)
  14. 4 Planned sale See Remarks sold 38,750 shares at an average $97.84 ($3,791,445)
  15. 4 Other disposition 10% owner disposed of 450,779 shares (other)
  16. 4 Other disposition Director disposed of 450,779 shares (other)
  17. 4 Conversion 10% owner acquired 7,707,188 shares (conversion)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Grant or award Director acquired 4,896 shares (grant or award)
  20. 3 Insider Initial Statement of Ownership

Page 3 of 5 · 87 filings